Peter Ellmark

Medicine & Life Sciences

1. Antibodies 100%
2. T-Lymphocytes 71%
3. Neoplasm Antigens 48%
4. Neoplasms 46%
5. B-Lymphocytes 41%
6. Anti-Idiotypic Antibodies 40%
7. Immunotherapy 37%
8. CD40 Ligand 37%
9. Immunoglobulin Fragments 35%
10. Urinary Bladder Neoplasms 35%
11. Single-Chain Antibodies 35%
12. Proteins 30%
13. Proteome 30%
14. ADC-1013 29%
15. Directed Molecular Evolution 22%
16. Pancreatic Neoplasms 22%
17. Dendritic Cells 22%
18. Cross-Priming 22%
19. Bacteriophages 21%
20. Bispecific Antibodies 21%
21. HIV-1 20%
22. Adenocarcinoma 20%
23. Nitrilotriacetic Acid 20%
24. Proteomics 19%
25. Epitopes 19%
26. Monoclonal Antibodies 18%
27. CD Antigens 18%
28. Immune System 16%
29. Ink 15%
30. Antigens 15%
31. Therapeutics 15%
32. Breast Neoplasms 15%
33. Streptavidin 15%
34. Biomimetics 14%
35. Technology 14%
36. Apoptosis 14%
37. Cancer Vaccines 14%
38. Libraries 14%
39. Growth 13%
40. Antigen-Presenting Cells 13%
41. Pharmacogenetics 13%
42. Membrane Lipids 13%
43. Blood Proteins 13%
44. Histidine 13%
45. Biotin 12%
46. Adsorption 12%
47. Helicobacter Infections 12%
48. Lymphoma 12%
49. Genomics 11%
50. Colorectal Neoplasms 11%